Hiroaki Shibahara

Creative Commons, Hyogo Medical University

Papers

2

Total Citations

7

H-Index

2

About

Dr. Hiroaki Shibahara is a leading figure in gynecologic oncology, with a focused expertise in the surgical management of endometrial cancer and benign gynecological diseases. His major contributions center on optimizing perioperative care for high-risk patients, particularly those with severe obesity. His highly cited 2023 work demonstrates how weight-loss interventions combined with levonorgestrel IUS implantation can significantly reduce surgical risks in early-stage endometrial cancer and atypical hyperplasia, offering a safer pathway to definitive treatment. This research directly addresses the critical intersection of obesity and surgical morbidity in minimally invasive gynecologic surgery. Additionally, Dr. Shibahara led a landmark nationwide survey in Japan (2022) that quantified the profound impact of the COVID-19 pandemic on benign gynecological surgeries, providing essential data for healthcare resource planning. With his work accumulating citations and shaping clinical protocols, Dr. Shibahara is recognized for pioneering patient-centered strategies that expand surgical eligibility and improve outcomes for some of the most challenging cases in gynecologic oncology.

Research Focus

Key Achievements

2
H-Index
2
Papers
7
Total Citations
4
Avg Citations/Paper
🏆 Most Cited Paper
Weight-Loss Interventions and Levonorgestrel Intrauterine System Implantation for Early-Stage Endometrial Cancer and Atypical Endometrial Hyperplasia to Reduce Perioperative Risk of Severely Obese Patients
4 citations · 2023
📈 Most Prolific Year: 2023 (1 Papers)
🤝 Key Collaborators: 16
🏛 Institutions: Creative Commons, Hyogo Medical University

Top Papers

  1. 1
  2. 2

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago